Adrian Ciurea

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano et al. · Annals of the Rheumatic Diseases · 2022 · 808 citations · Full text

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

Christoph Molnar, Almut Scherer, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases · 2017 · 249 citations · Full text

Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections

Lukas Hunziker, Mike Recher, Andrew J. Macpherson et al. · Nature Immunology · 2003 · 233 citations · Full text

Viral Persistence, Autoimmune Disease, Pathogenesis +7

Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis

Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea et al. · Arthritis Care & Research · 2009 · 209 citations · Full text

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

Axel Finckh, Adrian Ciurea, Laure Brulhart et al. · Arthritis & Rheumatism · 2007 · 209 citations